CN103202949B - Traditional Chinese medicine for treating chloasma by using cardiospermum halicacabum - Google Patents

Traditional Chinese medicine for treating chloasma by using cardiospermum halicacabum Download PDF

Info

Publication number
CN103202949B
CN103202949B CN201310067608.1A CN201310067608A CN103202949B CN 103202949 B CN103202949 B CN 103202949B CN 201310067608 A CN201310067608 A CN 201310067608A CN 103202949 B CN103202949 B CN 103202949B
Authority
CN
China
Prior art keywords
parts
radix
cardiospermum halicacabum
chinese medicine
traditional chinese
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201310067608.1A
Other languages
Chinese (zh)
Other versions
CN103202949A (en
Inventor
余金标
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201310067608.1A priority Critical patent/CN103202949B/en
Publication of CN103202949A publication Critical patent/CN103202949A/en
Application granted granted Critical
Publication of CN103202949B publication Critical patent/CN103202949B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a traditional Chinese medicine for treating chloasma by using cardiospermum halicacabum. The medicine comprises the following raw materials by weight: 18-22 parts of alum, 4-8 parts of the root of kudzu vine, 4-8 parts of manyleaf meadowure rhizome and root, 6-10 parts of Cineraria repanda, 6-10 parts of Cynanchum atratum Bge., 6-10 parts of ginseng, 4-8 parts of radices tinosporae, 1-5 parts of angelica, 1-5 parts of Flos Sophorae, 8-12 parts of Ligustrum malongense, 18-22 parts of angelica root, 8-12 parts of Sorrel, 28-32 parts of cardiospermum halicacabum and 28-32 parts of common bletilla tuber. The formula provided by the invention uses characteristics of cardiospermum halicacabum, and combines traditional Chinese medicines with effects of clearing heat, purging intense heat, cooling blood and detoxifyitng, and has good effects for the treatment of facial melasma, and has no toxic or side effects.

Description

A kind of Chinese medicine that utilizes Cardiospermum halicacabum treatment chloasma
technical field:
The present invention relates generally to the field of Chinese medicines, relates in particular to a kind of Chinese medicine that utilizes Cardiospermum halicacabum treatment chloasma.
background technology:
Chloasma is commonly called as " butterfly spot ", " chloasma hepaticum " or " cyasma ".Mainly occur in face, take cheekbone portion, buccal, nose, forehead, chin portion as main.For the brown of obscure boundary Chu or the patch of black, mostly be symmetry.Morbidity has many-sided reason, as chronic hepatorenal disease, and gestation, oral excessive contraceptive, Exposure to Sunlight, menoxenia etc.At present, Chinese and western medicine has the method for fine treatment chloasma, but effect is not good.
summary of the invention:
The object of the invention is exactly the defect in order to make up prior art, and a kind of Chinese medicine that utilizes Cardiospermum halicacabum treatment chloasma is provided, the successful of its treatment chloasma.
The present invention is achieved by the following technical solutions:
A Chinese medicine that utilizes Cardiospermum halicacabum treatment chloasma, is characterized in that: the weight proportion of its each raw material components is: dried Alumen 18-22, Radix Puerariae 4-8, Radix et Rhizoma Thalictri 4-8, Herba Senecionis Scandentis 6-10, Radix Cynanchi Atrati 6-10, Radix Ginseng 6-10, Radix Tinosporae 4-8, Radix Angelicae Sinensis 1-5, Flos Sophorae 1-5, Ligustrum malongense B. S. Sun 8-12, Radix Angelicae Dahuricae 18-22, Oxalis corniculata Linn. 8-12, Cardiospermum halicacabum 28-32, Pseudobulbus Bletillae (Rhizoma Bletillae) 28-32.
A Chinese medicine that utilizes Cardiospermum halicacabum treatment chloasma, is characterized in that: the weight proportion of its each raw material components is: dried Alumen 20, Radix Puerariae 6, Radix et Rhizoma Thalictri 6, Herba Senecionis Scandentis 8, Radix Cynanchi Atrati 8, Radix Ginseng 8, Radix Tinosporae 6, Radix Angelicae Sinensis 3, Flos Sophorae 3, Ligustrum malongense B. S. Sun 10, the Radix Angelicae Dahuricae 20, Oxalis corniculata Linn. 10, Cardiospermum halicacabum 30, the Pseudobulbus Bletillae (Rhizoma Bletillae) 30.
Cardiospermum halicacabum: [meridian distribution of property and flavor] is bitter, micro-pungent, cold.[function cures mainly] dissipating blood stasis for subsidence of swelling, removing pathogenic heat from blood and toxic substance from the body.
Advantage of the present invention is:
The present invention's formula utilizes Cardiospermum halicacabum characteristic, coordinates the Chinese medicine of clearing away heat-fire, removing pathogenic heat from blood and toxic substance from the body, for treatment chloasma faciei good effect, has no side effect.
the specific embodiment:
A Chinese medicine that utilizes Cardiospermum halicacabum treatment chloasma, the weight (g) of its each raw material components is: dried Alumen 20, Radix Puerariae 6, Radix et Rhizoma Thalictri 6, Herba Senecionis Scandentis 8, Radix Cynanchi Atrati 8, Radix Ginseng 8, Radix Tinosporae 6, Radix Angelicae Sinensis 3, Flos Sophorae 3, Ligustrum malongense B. S. Sun 10, the Radix Angelicae Dahuricae 20, Oxalis corniculata Linn. 10, Cardiospermum halicacabum 30, the Pseudobulbus Bletillae (Rhizoma Bletillae) 30.
Take above-mentioned formula, pulverize, water furnishing plaster.Detailed directions is: every night plaster is floated on the face, wash away second day early morning, and general, about one month, chloasma can obviously disappear.
For proving that the present invention has good curative effect, enumerate model case as follows:
Case one:
Week certain, female, 28 years old, main suit: skin of face is yellow dark matt, and two zygomatic arch directors have large-area lamellar speckle.The course of disease more than 2 years, is diagnosed as chloasma faciei, and routine medication has no and is clearly better.Give plaster of the present invention, be used in conjunction after January, facial colour spot is clearly better, and color is thin out.
Case two:
Model, female, 32 years old, main suit: facial speckle more than 3 years.Sign: skin lesion is distributed in face, is a moon shape, point-like chloasma, is diagnosed as chloasma faciei through department of dermatologry.Give every night above-mentioned ointment and apply face, wash away morning next day, is used in conjunction after January, and facial colour spot is clearly better, and color is thin out, adheres to medication two months, and forehead and facial colour spot disappear substantially.
Case three:
Liu, female, 40 years old, main suit: the brown spot of several pieces out-of-shapes and crescent shape is seen by buccal portion, without hepatopathy and endocrine system disease, was diagnosed as chloasma faciei on inspection.Give every night above-mentioned ointment and apply face, wash away morning next day, is used in conjunction after January, and facial colour spot obviously goes down.

Claims (2)

1. a Chinese medicine that utilizes Cardiospermum halicacabum treatment chloasma, is characterized in that: the weight proportion of its each raw material components is: dried Alumen 18-22, Radix Puerariae 4-8, Radix et Rhizoma Thalictri 4-8, Herba Senecionis Scandentis 6-10, Radix Cynanchi Atrati 6-10, Radix Ginseng 6-10, Radix Tinosporae 4-8, Radix Angelicae Sinensis 1-5, Flos Sophorae 1-5, Ligustrum malongense B. S. Sun 8-12, Radix Angelicae Dahuricae 18-22, Oxalis corniculata Linn. 8-12, Cardiospermum halicacabum 28-32, Pseudobulbus Bletillae (Rhizoma Bletillae) 28-32;
The preparation method of the described Chinese medicine that utilizes Cardiospermum halicacabum treatment chloasma is: get above-mentioned formula, pulverize, water furnishing plaster.
2. a kind of Chinese medicine that utilizes Cardiospermum halicacabum treatment chloasma according to claim 1, is characterized in that: the weight proportion of its each raw material components is: dried Alumen 20, Radix Puerariae 6, Radix et Rhizoma Thalictri 6, Herba Senecionis Scandentis 8, Radix Cynanchi Atrati 8, Radix Ginseng 8, Radix Tinosporae 6, Radix Angelicae Sinensis 3, Flos Sophorae 3, Ligustrum malongense B. S. Sun 10, the Radix Angelicae Dahuricae 20, Oxalis corniculata Linn. 10, Cardiospermum halicacabum 30, the Pseudobulbus Bletillae (Rhizoma Bletillae) 30.
CN201310067608.1A 2013-03-04 2013-03-04 Traditional Chinese medicine for treating chloasma by using cardiospermum halicacabum Expired - Fee Related CN103202949B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310067608.1A CN103202949B (en) 2013-03-04 2013-03-04 Traditional Chinese medicine for treating chloasma by using cardiospermum halicacabum

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310067608.1A CN103202949B (en) 2013-03-04 2013-03-04 Traditional Chinese medicine for treating chloasma by using cardiospermum halicacabum

Publications (2)

Publication Number Publication Date
CN103202949A CN103202949A (en) 2013-07-17
CN103202949B true CN103202949B (en) 2014-06-04

Family

ID=48750503

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310067608.1A Expired - Fee Related CN103202949B (en) 2013-03-04 2013-03-04 Traditional Chinese medicine for treating chloasma by using cardiospermum halicacabum

Country Status (1)

Country Link
CN (1) CN103202949B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103655361B (en) * 2013-12-19 2015-07-15 青岛琴诚医药技术有限公司 Traditional Chinese medicinal hand lotion

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1363269A (en) * 2001-01-01 2002-08-14 汪春华 Spot-removing antiwrinkle cream
CN1977811A (en) * 2005-12-02 2007-06-13 上海莲氏轩生物工程有限公司 Plant spot-removing function lotion
CN101810780A (en) * 2010-04-30 2010-08-25 黄泳葛 Spot-dispelling and whitening medicaments and treatment method

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1363269A (en) * 2001-01-01 2002-08-14 汪春华 Spot-removing antiwrinkle cream
CN1977811A (en) * 2005-12-02 2007-06-13 上海莲氏轩生物工程有限公司 Plant spot-removing function lotion
CN101810780A (en) * 2010-04-30 2010-08-25 黄泳葛 Spot-dispelling and whitening medicaments and treatment method

Also Published As

Publication number Publication date
CN103202949A (en) 2013-07-17

Similar Documents

Publication Publication Date Title
CN103386044B (en) Traditional Chinese medicine preparation for treating allergic rhinitis
CN102302751B (en) Chinese medicine for treating migraine
CN103202949B (en) Traditional Chinese medicine for treating chloasma by using cardiospermum halicacabum
CN102552788A (en) Defend Chinese medicine composite capable of preventing abortion
CN103110873A (en) Ointment for treating chloasma faciei
CN102579917B (en) Traditional Chinese medicine for treating psoriasis
CN102847004B (en) Traditional Chinese medicine for treating psoriasis by using cornu bubali
CN105596470A (en) Traditional Chinese medicine composition for treating allergic rhinitis and preparation method thereof
CN102552711B (en) Traditional Chinese medicine composition for treating hypertension
CN103330903A (en) Chinese medicine for preventing abortion
CN103566115A (en) Traditional Chinese medicine composition for treating arthralgia and myalgia
CN103386051B (en) One treats psoriatic Chinese medicine and preparation method thereof
CN103110711A (en) Traditional Chinese medicine for treating rhinitis through utilizing root of ivy tree
CN104906286A (en) Traditional Chinese medicine composition for treating stroke and arthralgia
CN103599479B (en) A kind of Chinese medicine for the treatment of liver-kidney yin deficiency apoplexy
CN104116903A (en) Traditional Chinese medicine for treating acute upper respiratory infection
CN103656405B (en) Traditional Chinese medicine composition for treating vulvar dystrophy, as well as preparation method and external preparation thereof
CN103099950A (en) Traditional Chinese medicine preparation for treating anemogenous toothache
CN105213570A (en) A pharmaceutical composition for treating solar dermatitis and its preparation method
CN102961593B (en) Traditional Chinese medicine for treating male infertility by devil rush rhizome
CN102961576B (en) Traditional Chinese medicine for treating dropsical nephritis by Pipet puberulilimbum
CN104069353A (en) Traditional Chinese medicine for treating pelvic inflammation
CN120324553A (en) A traditional Chinese medicine compound for nourishing yin, clearing heat and removing blood stasis for treating primary Sjögren's syndrome combined with renal tubular acidosis and its preparation method
CN104547693A (en) Traditional Chinese medicine for treating night sweat and spontaneous perspiration
CN104383311A (en) Traditional Chinese medicine composition for treating spontaneous perspiration and night sweat

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20140604

Termination date: 20160304

CF01 Termination of patent right due to non-payment of annual fee